(Olmesartan and Valsartan Anti-atherosclerosis Trial in Patients with Mild-Hypertension: Using Three-dimensional serial IVUS)Study

INTERVENTION: 1) Olmesartan 2) Valsartan CONDITION: stable angina pectoris with mild hypertension PRIMARY OUTCOME: nominal changes in % plaque volumes by three‐dimensional intravascular ultrasound at 6‐8 months follow‐up after percutaneous coronary intervention SECONDARY OUTCOME: (IMT); change from baseline in mean IMT after 6‐8 months; (E/A); change from baseline in E/A after 6‐8 months by echocardiography; (laboratory test); hs‐CRP, adiponectine, aldosterone, renin, oxLDL, HOMA‐R, TC, TG, LDL‐C, HDL‐C, etc INCLUSION CRITERIA: Patients with mild hypertension, who have been treated with statins more than 8 weeks before the randomization